RxDoctor Payments Data

James Anderson, MD

Family Medicine · Kingston Springs, TNNPI 1184620460

Payments from drug & device makers

$10,062in general payments, 2019–2025

Across 639 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • AbbVie$1K
  • Lilly USA, LLC$525
  • Boehringer Ingelheim$446
  • Pfizer$422
  • plus $5K from 44 others

What the payments were for

  • Food & beverage$9,96299%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,062 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$152,711
Medicare patients
431
Services billed
3,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban640$256,804
XareltoRivaroxaban268$127,735
Trelegy ElliptaFluticasone/Umeclidin/Vilanter169$118,505
FarxigaDapagliflozin Propanediol116$113,333
OzempicSemaglutide85$102,378
IngrezzaValbenazine Tosylate12$93,370
MounjaroTirzepatide79$90,295
TrulicityDulaglutide147$83,094
JardianceEmpagliflozin101$71,571
MyrbetriqMirabegron174$53,363
JanuviaSitagliptin Phosphate139$51,631
XifaxanRifaximin13$42,001
AptiomEslicarbazepine Acetate43$25,783
LinzessLinaclotide34$25,612
GemtesaVibegron36$25,251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$422$267,298651 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$332$178,823294 claims
Lilly USA, LLCMounjaro, Trulicity$525$173,389226 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$1,180$148,240159 claims
Johnson & JohnsonXarelto$345$127,735268 claims
Novo NordiskOzempic$1,333$102,37885 claims
Neurocrine Biosciences, Inc.Ingrezza$53$93,37012 claims
Boehringer IngelheimJardiance$446$71,571101 claims
Astellas Pharma US IncMyrbetriq$287$53,363174 claims
MerckJanuvia$206$51,631139 claims
AbbVieLinzess, Qulipta, Namzaric$1,010$51,03995 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$414$42,00113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Kingston Springs

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →